Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Fimepinostat in Treating Brain Tumors in Children and Young Adults [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase 1 trial update on fimepinostat for pediatric and young adult brain tumors, including DIPG, recurrent anaplastic astrocytoma, glioblastoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fimepinostat (fimepinostat)

Snippet

Sponsor: Sabine Mueller, MD, PhD | Conditions: Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING